Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving hundreds of leading biopharmaceutical companies globally:

Fish and Richardson
Farmers Insurance
Baxter
Colorcon
UBS
Merck

Generated: September 19, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for ITI-007

  Try a free trial


See Plans and Pricing

« Back to Dashboard

US Patents for ITI-007

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
ITI-007 ➤ Sign Up Substituted pyrido[3',4':4,5]pyrrolo[1,2,3-de]quinoxalines for inhibiting serotonin reuptake transporter activity INTRA-CELLULAR THERAPIES, INC. (New York, NY) ➤ Sign Up
ITI-007 ➤ Sign Up Organic compounds INTRA-CELLULAR THERAPIES, INC. (New York, NY) ➤ Sign Up
ITI-007 ➤ Sign Up Compounds and methods of use to treat schizophrenia INTRA-CELLULAR THERAPIES, INC. (New York, NY) ➤ Sign Up
ITI-007 ➤ Sign Up Preparation of certain substituted [((6bR,10aS)-2,3,6b,7,8,9,10,10a-octahydro-1H-pyrido[3',4':4,5]pyrrolo[1,- 2,3-de]quinoxalines and pharmaceutically acceptable salts thereof INTRA-CELLULAR THERAPIES, INC. (New York, NY) ➤ Sign Up
ITI-007 ➤ Sign Up Methods INTRA-CELLULAR THERAPIES, INC. (New York, NY) ➤ Sign Up
ITI-007 ➤ Sign Up Substituted heterocycle fused gamma-carbolines Bristol-Myers Squibb Pharma Company (Wilmington, DE) ➤ Sign Up
ITI-007 ➤ Sign Up Substituted heterocycle fused gamma-carbolines Bristol-Myers Squibb Pharma Company (Princeton, NJ) ➤ Sign Up
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

Subscribe to access the full database, or try a Free Trial

International Patents for ITI-007

Drugname Country Document Number Estimated Expiration Related US Patent
ITI-007 European Patent Office 2968320 2033-03-15 ➤ Sign Up
ITI-007 Hong Kong 1220615 2033-03-15 ➤ Sign Up
ITI-007 World Intellectual Property Organization (WIPO) 2014145192 2033-03-15 ➤ Sign Up
ITI-007 Australia 2015240521 2034-04-04 ➤ Sign Up
ITI-007 Canada 2944512 2034-04-04 ➤ Sign Up
ITI-007 China 106535898 2034-04-04 ➤ Sign Up
ITI-007 European Patent Office 3125893 2034-04-04 ➤ Sign Up
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cipla
Daiichi Sankyo
Harvard Business School
Queensland Health
Covington
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.